Biotechnology Company
Risk Evaluation Mitigation Strategies, industry user fees, S.934 - FDA Reauthorization Act of 2017, H.R. 2430-FDA Reauthorization Act of 2017, H.R. 2212-CREATES Act of 2017, S. 974-CREATES Act of 2017
HCR - Health Issues
1 - SENATE
FIERCE GOVERNMENT RELATIONS
1155 F Street NW, Suite 950, Washington, DC, 20004, US
WILLIAM KIRK BLALOCK MICHAEL CHAPPELL KIRSTEN CHADWICK ALEIX JARVIS KATE HULL WILLIAM PIPER DANIELLE MAURER TYLER STEPHENS ERIC ZULKOSKY